Literature DB >> 21081288

Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.

Ryan J Hansen1, Bradley J Samber, Daniel L Gustafson.   

Abstract

Felbamate (2-phenyl-1,3-propanediol dicarbamate) is a second generation antiepileptic drug used to treat seizures refractory to other antiepileptic drugs. With approximately 3500 new patients exposed annually, several important pharmacologic interaction questions remain unanswered necessitating the need for rapid and accurate methods of felbamate analysis in biological matrices. To this end, a rapid liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed for the measurement of felbamate in mouse plasma and tissues and human plasma. Plasma (100 μL) and tissues homogenates (100 μL of 100 mg/mL) were spiked with internal standard (carisoprodol) prior to protein precipitation with acetonitrile. Samples were chromatographed on a XBridge Phenyl, 2.5 μm, 4.6 mm×50 mm column with quantitation by internal standard reference monitoring of the ion transitions m/z 239→117 for felbamate and m/z 261→176 for carisoprodol. Calibration curves were linear from 2.5 to 500 ng/mL in mouse or human plasma and 25-5000 pg/mg in tissue homogenates. Recoveries were greater than 97% for plasma and homogenates with accuracies >92% in any of the mouse matrices and >88% in human plasma. Comparable accuracies and precision were found with and without the use of the internal standard in preparation of the calibration curves and suggest that the internal standard may not be required.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081288      PMCID: PMC4278804          DOI: 10.1016/j.jchromb.2010.10.006

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  15 in total

1.  Drug monitoring and toxicology: a simple procedure for the monitoring of felbamate by HPLC-UV detection.

Authors:  Peter H Tang
Journal:  J Anal Toxicol       Date:  2008-06       Impact factor: 3.367

2.  Felbamate-associated fatal acute hepatic necrosis.

Authors:  M G O'Neil; C S Perdun; M B Wilson; S T McGown; S Patel
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

3.  Felbamate therapy in the Lennox-Gastaut syndrome.

Authors:  S R Snodgrass
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

4.  An automated analytical method for the determination of felbamate in human plasma by robotic sample preparation and reversed-phase high performance liquid chromatography.

Authors:  J Hempenius; G Hendriks; J Hingstman; C K Mensink; J H Jonkman; C C Lin
Journal:  J Pharm Biomed Anal       Date:  1994-11       Impact factor: 3.935

5.  Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids.

Authors:  C D Thompson; M T Barthen; D W Hopper; T A Miller; M Quigg; C Hudspeth; G Montouris; L Marsh; J L Perhach; R D Sofia; T L Macdonald
Journal:  Epilepsia       Date:  1999-06       Impact factor: 5.864

6.  Population pharmacokinetics of felbamate in children.

Authors:  M T Kelley; P D Walson; S Cox; L J Dusci
Journal:  Ther Drug Monit       Date:  1997-02       Impact factor: 3.681

7.  The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.

Authors:  C R Banfield; G R Zhu; J F Jen; P K Jensen; R C Schumaker; J L Perhach; M B Affrime; P Glue
Journal:  Ther Drug Monit       Date:  1996-02       Impact factor: 3.681

8.  Aplastic anemia in a patient receiving felbamate for complex partial seizures.

Authors:  P B Pennell; M S Ogaily; R L Macdonald
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

9.  Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.

Authors:  V Saano; P Glue; C R Banfield; P Reidenberg; R D Colucci; J W Meehan; P Haring; E Radwanski; A Nomeir; C C Lin
Journal:  Clin Pharmacol Ther       Date:  1995-11       Impact factor: 6.875

10.  Efficacy of felbamate in therapy for partial epilepsy in children.

Authors:  L Carmant; G L Holmes; S Sawyer; N Rifai; J Anderson; M A Mikati
Journal:  J Pediatr       Date:  1994-09       Impact factor: 4.406

View more
  1 in total

1.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.